Werken bij Siemens HealthineersPersInvestor Relations
  1. Home
  2. Visie & perspectief
  3. Comprehensive Cancer Care Pathway

Addressing the entire cancer care pathway 

Creating a world without fear of cancer 

Oncology care is becoming increasingly relevant for healthcare organizations and professionals. Overall cancer rates are increasing due to rising life expectancy and growing populations. In 2030, more than 21 million men and women worldwide could develop cancer – 50% more than in 20121.

Belgium is also impacted as we can see in the figures below:

  • The disease affects approximately one in three men and one in four women before they reach the age of 75.
  • 30.079 Belgians died of cancer in 2020 which represents approximately 82 per day
  • The incidence of cancer is greater in Belgium than the EU average
  • The most common cancers are: 


Cancers in Belgium

With recent advancements in treatment options, life expectancy for cancer patients has dramatically improved. Imaging technology that enables earlier detection, highly customized types of radiation therapy, targeted chemo- and immunotherapies have made this possible.

Cancer is a complex disease that requires a multidisciplinary approach to care. At Siemens Healthineers, we offer a comprehensive portfolio of products and services that enable accurate diagnosis, personalized treatment planning, and precise delivery of therapy. Our solutions are designed to meet the needs of each unique patient and help providers optimize their workflows for maximum efficiency.

Our comprehensive cancer care solutions are present during the whole patient journey

Patient journey - cancer care

1. Screening and Early Detection: Early detection is key to successful cancer treatment. Siemens Healthineers offers a wide range of advanced imaging technologies for cancer screening, including MRI, CT, and PET/CT systems. These imaging technologies provide high-quality images that help physicians identify cancer at its earliest stages, when treatment is most effective. Furthermore, our software solutions offer powerful tools for image analysis and reporting to support accurate and efficient diagnosis.

2. Diagnosis and Therapy Decision: After cancer has been detected, the next step is diagnosis and therapy decision. Siemens Healthineers provides a variety of diagnostic solutions that aid healthcare professionals in identifying the type and severity of cancer. Our technologies include biopsy systems, molecular diagnostics, and pathology solutions. With these tools, healthcare providers can make better informed decisions about the most appropriate treatment for each patient. 

3. Treatment Planning and Delivery: Once a treatment plan has been established, Siemens Healthineers offers a range of technologies for treatment planning and delivery. Our radiation therapy solutions include linear accelerators, brachytherapy systems, and treatment planning software. These technologies enable providers to deliver precise doses of radiation to cancerous tissues while minimizing exposure to healthy tissues. We also offer software solutions that enable providers to create personalized treatment plans based on each patient's unique needs.

4. Follow-up and Survivorship: After treatment is complete, follow-up is critical for long-term health and well-being. Siemens Healthineers assists patients throughout their healthcare journey with solutions tailored to their needs. Our solutions include patient monitoring technologies, remote and patient engagement software. These technologies enable patients to stay connected with their healthcare providers and stay informed about their health status.

Our Digital Platforms

Technological advancements in the medical field have led to the development of digital solutions to aid in the management of cancer patients. Noona and Syngo Carbon are two examples of these digital solutions that provide comprehensive assistance for patient monitoring. By using these tools, clinicians can provide personalized treatment based on the individual needs of the patient. While improving his quality of life, it also offers the patient more accurate and offering regular monitoring.

1. International Agency for Research on Cancer, Globocan 2012: http://globocan.iarc.fr/Pages/burden_sel.aspx

2. https://gco.iarc.fr/today/data/factsheets/populations/56-belgium-fact-sheets.pdf